Some wording in the blog today is different to the NOX release of 27 Dec and the announcement today from KZA.
Previously both companies had made reference to a collaboration, including that NOX 27 Dec release......whereas the blog in one sentence today clearly suggests payment was made to clear NOX of any KZA claims over the IP.
This is really an important point. All the previous talk of collaboration means both companies can go about their business while working together for mutual benefit.
My owns thoughts would be that KZA still believe THEY own the IP ......but are prepared to allow NOX to develop their drug program and go on and market/profit form any future sales. The key point thought is that KZA also would have access to any NOX trial or development success.
Shaking your head maybe......well here is something else. Last Tuesday 16, KAZIA changed their Cantrixil Clinical/Trials gov. website to show now - "sharing of IP ".
This is just my speculation, but I think KZA management may be a bit peeved at the wording in the blog today.
- Forums
- ASX - By Stock
- Blog re NOX-KZA agreement
Some wording in the blog today is different to the NOX release...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.22M |
Open | High | Low | Value | Volume |
10.0¢ | 10.5¢ | 9.9¢ | $4.773K | 48.10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20574 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 38542 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 620344 | 0.110 |
1 | 9523 | 0.105 |
5 | 149890 | 0.100 |
1 | 25357 | 0.098 |
2 | 176978 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 106914 | 1 |
0.125 | 128094 | 1 |
0.130 | 166171 | 3 |
0.135 | 199760 | 1 |
0.140 | 230213 | 8 |
Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
NOX (ASX) Chart |